News - Page 8

Hilde O. Vandeskog has been a visiting scholar at Boğaziçi University in Istanbul.

A doctor discovers bacteria in a sample that is causing a case of pneumonia and prescribes antibiotics. But at the same time, there is another, nastier variant of bacteria lurking in the patient’s body that is very glad to have got rid of its competitor. 

If you have a stroke, the protein FSAP may help to reduce the extent of paralyses and problems with speech.

Professor Stenmark receives the prestigious award for his pioneering studies of processes in cell membranes, and how misregulation of such processes affects the development of cancer.

Pahnke has been awarded the Oswald Schmiedeberg prize for pharmacology. He receives the prize for his research on, and development of, new drugs for dementia and movement disorders.

In the Middle Ages, people of high status were both taller and had higher bone density than those from modest backgrounds. This difference was most marked amongst women, shows a new study based on the Schreiner Collection.

Did you miss this seminar? Follow a short recap of the presentations provided by national and international speakers.

Anita Kavlie, national coordinator for EATRIS Norway, has been involved in writing and organizing a new free MOOC developed under the European Joint Program of Rare Diseases with the title Introduction to translational research for Rare Diseases.

Anna is a postdoctoral researcher who recently started at the Haapaniemi group.

Alongside the 2022 Lancet Countdown Report on Health and Climate Change, a Policy Brief for Norway has been published for the second year in a row! Read the full report including the full briefing and recommendations from the policy brief.

The Norwegian Ministry of Health and Care Services and the Centre for Global Health at the University of Oslo hosted a symposium entitled, A World in Transitions: Implications for Priorities and Efficiencies in Global Health on October 14, 2022.

The study used HDX-MS to map the epitope and paratope of the new high-affinity tumor-specific antibody developed against a variant of HER2. Antibodies directed against HER2 are already used in breast cancer therapy, and the new antibody developed by the collaboration has potential to be used as a diagnostic tool or future cancer treatment.

You are sitting in a meeting at work and your mind starts to wander to another place. Suddenly, you realise that the person leading the meeting has asked you a question that you have not heard. Why does this happen?

Fifty students have gained work experience from a research project with a scholarship from UiO:Life Science this summer. The end of this year's summer projects was celebrated with presentations, poster exhibition and prize ceremony.

Why does it become harder to concentrate when you have Alzheimer’s disease? The explanation is perhaps that the signals transmitted from glial cells to nerve cells are disrupted.

Head of Institute Dag Kvale and Deputy Heads of Institute Shuo-Wang Qiao and Torbjørn Omland look forward to lead the institute through a new four-year period.

NCMM Group Leader Dr Emma Haapaniemi will collaborate with centre leaders and NCMM Associate Investigators Prof Johanna Olweus and Prof Karl-Johan Malmberg as part of the new centre, Precision Immunotherapy Alliance (PRIMA).

The University of Oslo, organised in collaboration with the Norwegian University of Life Sciences (NMBU), the event "Is there hope for the Oslofjord" on 29 September. The theme arouses great interest and many people participated in Domus Bibliotheca.

In autumn 2021, six new convergence environments were granted funding for a period of four years. The interdisciplinary research groups have started up during 2022 and are well underway with the recruitment of PhDs and Postdoctoral fellows for their research projects.

Arnoldo Frigessi and Arne Klungland are granted Norwegian Centres of exellence.

Join our team and support our mission to advance capacity for global health research, education, and communication at the University of Oslo and partner institutions. 

Hanne Flinstad Harbo won the election for the position of dean at the Faculty of Medicine with 53% of the votes. She will be the faculty's first female dean.

The new Jebsen centre opened on 1 September and will have a duration of five years. The aim of the centre's research is to improve the prevention and treatment of heart disease. The Centre is led by Professor Torbjørn Omland.

Five research environments from MED reached this year's FRIPRO award. One research environment from IMB and four from Klinmed received support.

Jeanette H. Magnus, Director of the Centre for Global Health at UiO contributed to discussions for a long-term plan for higher education and research at Universitets- og høgskolerådet (UHR) by presenting different paradigms and perspectives.